Repligen CorporationRGENNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +7.58% | +10.44% | +14.81% | +21.91% | +18.12% |
| Gross Profit Growth | -42.55% | +18.19% | +24.27% | +29.72% | +140.58% |
| EBITDA Growth | -77.85% | +21.16% | +34.41% | +119.38% | +2031.61% |
| Operating Income Growth | +0.00% | +75.41% | +86.75% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +76.88% | +160.21% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +150.00% | +337.71% | -15.62% | +0.00% |
| EPS Diluted Growth | +0.00% | +150.00% | +342.18% | -18.75% | +0.00% |
| Weighted Average Shares Growth | +0.43% | +0.60% | +0.53% | +0.35% | +0.83% |
| Weighted Average Shares Diluted Growth | +0.43% | +0.05% | +0.13% | -0.74% | +0.83% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +34.79% | -66.44% | -32.19% | -2.48% | -34.39% |
| Free Cash Flow Growth | +79.34% | -70.90% | -39.63% | +1.26% | -47.04% |
| Receivables Growth | +8.02% | +27.34% | +27.35% | +15.46% | +18.25% |
| Inventory Growth | -29.34% | -22.68% | -18.19% | -12.14% | +19.23% |
| Asset Growth | -0.05% | +0.10% | +1.39% | +3.29% | +4.24% |
| Book Value per Share Growth | -0.03% | +0.16% | +3.25% | +2.93% | +5.88% |
| Debt Growth | -3.59% | -7.32% | -7.64% | +2.44% | +0.54% |
| R&D Expense Growth | +13.53% | +15.00% | +35.63% | +45.98% | +4.34% |
| SG&A Expenses Growth | +5.15% | +15.29% | +28.09% | -2.58% | +3.69% |